Quarterly Result6 Nov 2026, 07:22 pm
Kabra Drugs Declares Un-audited Q2 FY27 Results
AI Summary
Kabra Drugs Ltd (now Aanjaay Industries Limited) announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved the financial statements along with the limited review report from the statutory auditors. The company operates in a single business segment and has no subsidiaries or associate entities. Exceptional items for the period included bad debts written off amounting to ₹39.61 Lakhs.
Key Highlights
- Board approved un-audited financial results for Q2 FY27.
- Limited review report from statutory auditors received.
- Company operates in a single business segment.
- Exceptional items include ₹39.61 Lakhs in bad debts.
- No subsidiaries or associate entities.
Price Impact
More from KABRADG